NCT02332798View on ClinicalTrials.gov

Multiple Ascending Doses of PF-04958242 in Subjects With Stable Schizophrenia

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

January 6, 2015

Primary Completion Date

April 15, 2015

Study Completion Date

April 15, 2015

Conditions
Schizophrenia
Interventions
DRUG

PF-04958242

Administered as specified in the treatment arm

DRUG

Placebo

Administered as specified in the treatment arm

Trial Locations (1)

90806

Collaborative Neuroscience Network, LLC., Long Beach

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY